Skip to main content
Midas Edge

Inspire Medical Systems Inc

For the period ended Sep 30, 2024. Filed Nov 4, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 4, 2024

INSP$64.33+0.5%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Statements of Stockholders' Equity

Consolidated Statements of Stockholders' Equity (unaudited)

(in thousands, except share amounts)

Nine Months Ended September 30, 2024
Common Stock
SharesAmountAdditionalPaid-InCapitalAccumulatedOtherComprehensiveIncome (Loss)AccumulatedDeficitTotalStockholders'Equity
Balance at December 31, 202329,560,464$30$917,107$800$(345,423)$572,514
Stock options exercised88,276—3,616——3,616
Vesting of restricted stock units41,185—————
Shares held for tax withholdings(14,373)—(2,848)——(2,848)
Issuance of common stock543—101——101
Stock-based compensation expense——26,322——26,322
Other comprehensive loss———(676)—(676)
Net loss————(10,005)(10,005)
Balance at March 31, 202429,676,09530944,298124(355,428)589,024
Stock options exercised88,328—5,517——5,517
Vesting of restricted stock units21,340—————
Shares held for tax withholdings(10,985)—(1,862)——(1,862)
Issuance of common stock365—85——85
Issuance of common stock for employee stock purchase plan30,158—3,431——3,431
Stock-based compensation expense——32,322——32,322
Other comprehensive loss———(239)—(239)
Net income————9,7939,793
Balance at June 30, 202429,805,30130983,791(115)(345,635)638,071
Stock options exercised152,106—14,226——14,226
Vesting of restricted stock units10,273—————
Issuance of common stock469—65——65
Shares held for tax withholdings(4,889)—(4,335)——(4,335)
Stock-based compensation expense——28,223——28,223
Other comprehensive income———1,815—1,815
Net income————18,49718,497
Balance at September 30, 202429,963,260$30$1,021,970$1,700$(327,138)$696,562

Consolidated Statements of Stockholders' Equity (unaudited)

(in thousands, except share amounts)

Nine Months Ended September 30, 2023
Common Stock
Shares · Amount · AdditionalPaid-InCapital · AccumulatedOtherComprehensive(Loss) Income · AccumulatedDeficit · TotalStockholders'Equity
Balance at December 31, 202229,008,368$29$820,335$(86)$(324,270)$496,008
Stock options exercised142,167—7,377——7,377
Vesting of restricted stock units18,852—————
Shares held for tax withholdings(6,750)—(1,746)——(1,746)
Issuance of common stock364—90——90
Stock-based compensation expense——18,225——18,225
Other comprehensive income———118—118
Net loss————(15,424)(15,424)
Balance at March 31, 202329,163,00129844,28132(339,694)504,648
Stock options exercised143,693—13,113——13,113
Vesting of restricted stock units9,349—————
Shares held for tax withholdings(3,237)—(971)——(971)
Issuance of common stock390—91——91
Issuance of common stock for employee stock purchase plan12,983—2,792——2,792
Stock-based compensation expense——21,567——21,567
Other comprehensive income———71—71
Net loss————(11,952)(11,952)
Balance at June 30, 202329,326,17929880,873103(351,646)529,359
Stock options exercised72,632—4,016——4,016
Vesting of restricted stock units6,272——
Issuance of common stock279—91——91
Shares held for tax withholdings(2,173)—(516)——(516)
Stock-based compensation expense——19,829——19,829
Other comprehensive loss———(59)—(59)
Net loss————(8,540)(8,540)
Balance at September 30, 202329,403,189$29$904,293$44$(360,186)$544,180
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.